Call for Abstract
Scientific Program
14th International Conference and Exhibition on Pharmaceutical Formulations, will be organized around the theme “Successful Formulation Strategies in Achieving Future Generation Advancements”
Formulations 2017 is comprised of 18 tracks and 109 sessions designed to offer comprehensive sessions that address current issues in Formulations 2017.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Pharmaceutical formulation is defined as the process in which different chemical substances are combined to produce a final medicinal product. The formulation studies involve developing a preparation of drug acceptable for patient. Formulation is the word often used in a way that includes dosage form. Formulation studies consider factors such as solubility, particle size, polymorphism and pH as all of these can influence bioavailability and hence the activity of a drug.
- Track 1-1Formulation and preformulation
- Track 1-2Developing a preparation of the drug
- Track 1-3Formulation types
- Track 1-4Formulation from plant sources
Solid dosage formulations are important dosage forms in pharmaceuticals. e.g. tablets, capsules, granules, sachets, reconstitutable powders, powders, dry powder inhalers and chewables. Solid dosage form contains unit dose of one or more medicament. Excipients include Binders, Glidants, Sweeteners etc.,
- Track 2-1Granulated formulations
- Track 2-2Types of preparations
- Track 2-3Chewable tablets
- Track 2-4Capsules
- Track 2-5Pills
- Track 2-6Lozenges
- Track 2-7Dental cones
- Track 2-8Granules
Semi solid dosage forms are the products when applied to the skin treat a pathological condition and protects from other harmful environment. They are smooth,non-staining and get miscible with skin secretions. Creams, Gels, Pastes etc are the examples.
- Track 3-1Ointments,creams
- Track 3-2Industrial processing
- Track 3-3Storage conditions
- Track 3-4Ideal properties
- Track 3-5Formulation
Liquid dosage forms are essential pharmaceutical products which involves a mixture of active drug components and nondrug components (excipients). Liquid dosage forms are prepared: a) by dissolving the active drug substance in an aqueous or non- aqueous (e.g. glycerin, ether, alcohol) solventb) By suspending the drug in appropriate medium or c) By incorporating the drug substance into an oil or water phase.Ex: Suspension, Emulsion, Syrups, Elixers
- Track 4-1Syrups/Suspension/Emulsion
- Track 4-2Preparation methods
- Track 4-3Used mainly for elderly and young children
- Track 4-4Oral Drops
- Track 4-5Elixirs
- Track 4-6Linctuses
- Track 4-7Gargles
- Track 4-8Advantages and disadvantages
Gaseous dosage forms are packed in a container which gets released upon applying pressure. The gas inside contains therapeutically active medicaments. The container have valve systems with continuous or limited delivery. They are used for topical application on skin and as local application into nose and mouth.Ex: Nebulizer,Sprays,Inhalers
- Track 5-1Sprays
- Track 5-2Vaporizer
- Track 5-3Aerosols
- Track 5-4Nebulizer or atomizer
- Track 5-5Inhalers
Formulations are classified into two types: based on Route of administration and Physical form. Based on route of administration they are classified as Oral, Topica, Rectal, Parenteral, Vaginal, Inhaled, Ophthalmic and octic
- Track 6-1 Types: Parenteral,Topical, Enternal
- Track 6-2 Routes of administration: Oral, Rectal,Vaginal, Lingual etc
- Track 6-3Inhalation formulations
- Track 6-4Formulation from plant source
- Track 6-5Other routes
- Track 6-6Advantages and disadvantages
“Novel Drug delivery System (NDDS) refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
- Track 7-1Nano technology
- Track 7-2Controlling pharmacokinetics and dynamic properties
- Track 7-3Drug delivery Carriers, Micelles, etc..,,
- Track 7-4Types of dosage forms
- Track 7-5Route of administration
Prior to formulation some physico chemical properties are characterized. Chemical properties include structure, form and reactivity. Physical properties include particle size, melting point and solubility. In case of some drugs biological properties are also characterized. Age and sex of the patient also play a major role in dosage design. The others factors are Solubility, Buffer capacity and partition coefficient
- Track 8-1Physical and chemicals considerations.
- Track 8-2Buffer capacity
- Track 8-3Partition coeficient
- Track 8-4Solubility and PH
- Track 8-5The phase rule
- Track 8-6Melting point depression
- Track 8-7Age and sex of patient
The drug subjected to drug development undergo number of trials and are screened at different stages to produce a final potent drug for the treatment of various diseases. During this process different properties are checked to see whether the drug is non-toxic to living system and is therapeutic or not. Using suitable excipients and technological preparations the active substances are formulated into final dosage form. The final product is the Actual composition of preparation, manufacturing specification.
- Track 9-1Types of coating and coating procedures
- Track 9-2Validation process
- Track 9-3Advanced formulation techniques
- Track 9-4Development of parenteral dosage form
- Track 9-5Development of oral dosage form
- Track 9-6Lyophilized dosage forms
Pharmaceutical excipients are those substances other than the prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. There are many excipients. Few of tehm include Antiadherents, Binders,Coatings, Colours, Flavours, Lubricants, Preservatives, Sweeteners etc..,
- Track 10-1Active ingredient of a medication
- Track 10-2Surfactants and glidants
- Track 10-3Emulsifying and suspending agents
- Track 10-4Disintergants and binders
- Track 10-5Preservatives and antioxidents
- Track 10-6Diluents and lubricants
- Track 10-7Stability enhancers
Drug design, also known as rational drug design, is the inventive process of finding new medications based on the knowledge of a biological target. Drug design defines the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
- Track 11-1Ligand based drug designs
- Track 11-2Structure based drug designs
- Track 11-3New chemical entity development
- Track 11-4Pre-clinical phase
- Track 11-5Clinical phase
- Track 11-6Cost
- Track 11-7Valuation
- Track 11-8Novel initiatives
- Track 11-9Success rate
Pharmaceutical analysis is a branch of practical chemistry that involves a series of process for qualification, purification, identification and determination of a substance, separation of the components of a solution or mixture, or determination of structure of chemical compounds. The sample to be analysed is called as analyse
- Track 12-1Quality control and quality assurance
- Track 12-2Chromatographic techniques
- Track 12-3Quantative and qualitative analysis
- Track 12-4Validation methods
- Track 12-5 Stoichiometry between reactants & products
The drug product manufacturing facility is designed to produce injectables in syringes or vials in Grade A environment. Industries strive to improve product quality in today’s competitive environment and as well reduces the production cost
- Track 13-1Sterile filteration,aseptic filling
- Track 13-2Process development tools
- Track 13-3Stability testing
- Track 13-4Capping, Sealing & Labelling
- Track 13-5Storage and handling of cold-chain products
- Track 13-6Pre and post gas flushing facility
Targeted drug delivery sometimes called smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to other parts in the mean time reduce side effects/toxicity of payloads which are key factors for improving patient compliance
- Track 14-1Mucosal drug delivery
- Track 14-2Gene delivery
- Track 14-3Nucleic acid based drug delivery systems
- Track 14-4Blood brain barrier delivery
- Track 14-5Self-emulsifying drug delivery systems
- Track 14-6Insulin dlivery
- Track 14-7Targeted drug delivery
- Track 14-8Proteins and surfaces
Pharmacists can play a role helping patients with chronic diseases have better medication at correct time and get good clinical outcomes. They play a key role in immunization services and identifying vaccine candidates. They Participate and maintain a significant role in multidisciplinary patient care rounds. Patients often make their own decisions about managing their medications. Pharmacists could usefully serve as patient advocates, providing information that permits patients to assess risk and enhance their autonomy.
- Track 15-1Key role in reducing adverse drug events
- Track 15-2Patient councelling
- Track 15-3Communication barriers
- Track 15-4Medical controversies
- Track 15-5Legal and practical aspects of prescribing
- Track 15-6Improving patient care in rural areas
- Track 15-7Reducing healthcare costs
- Track 15-8Improving patient safety
Regulatory affairs is a new profession which is developed by the governments to protect public health. The main aim is controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals and cosmetics. Regulatory affairs also has a very specific meaning within the healthcare industries.
- Track 16-1Intellectual property management
- Track 16-2New drug discovery/development
- Track 16-3Regulatory & pharmacovigilance
- Track 16-4Regulatory challenges for medical device
- Track 16-5Global regulatory intelligence
- Track 16-6Regulatory strategies and developments
- Track 16-7Clinical affairs & regulatory strategies
Pharma industries are showing increased confidence in the growth of manufacturing in the market. This turn around in the market is due to the potential which is being driven by concerns of quality in some Asian markets and a marketed shift in the drug development. The primary reason behind this is an increased regulatory confidence in the standards of manufacturing.
- Track 17-1Development in drug production and sales
- Track 17-2Growth in export and imports
- Track 17-3Environment for industry
Entrepreneurs who are ready to invest and get profit by working hard in the field of pharmaceutical formulations will be happy by attending this meeting and make their way a successful one by meeting intellectuals and experts who can make their investment worthwhile. This platform will be the best one to make a shape of your business.
- Track 18-1 Profit and loss in the production
- Track 18-2 Risks in production and sales